Answers are grounded in this paper and cite their sources.
Chronic inflammation is associated with oxidative stress and dysregulation of inflammatory mediators. Medicinal plants, such as Echinops spinosus L. (ES) have widely been used in traditional medicine for its beneficial effects and bioactive compounds. Therefore, the aim of this study was to conduct a phytochemical characterisation using UPLC-ESI-MS/MS and to evaluate in vitro the cytotoxicity, antioxidant (using DPPH, FRAP, and TAC assays), and anti-inflammatory activities (through red blood cell membrane stabilisation and bovine serum albumin denaturation assays) of ES flower head extracts. In addition, molecular docking of Chrysin-6-C-glucoside was performed to investigate its interaction with tumour necrosis factor-α (TNF-α) and dihydrofolate reductase (DHFR), which have not previously been investigated. The ethyl acetate fraction exhibited the highest antioxidant and anti-inflammatory properties with an IC50 of 18.44 ± 0.36 μg/mL and 4.29 ± 0.16 mg/mL, respectively. The UPLC-ESI-MS/MS analysis revealed 27 compounds, including Chrysin-6-C-glucoside, which demonstrated a binding affinity of −8.0 kcal/mol towards TNF-α and −8.8 kcal/mol towards DHFR. These results suggest the development of ES flower head extracts and Chrysin-6-C-glucoside as therapeutic anti-inflammatory agents.
No takes yet. Share an insight, caveat, or question.
Younes et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: